Warfarin treatment in patients with atrial fibrillation: Observing outcomes associated with varying levels of INR control

Thrombosis Research

Volumn 124, Issue 1, 2009, Pages 37-41

  Morgan, Christopher Ll ^a   McEwan, Phil ^a   Tukiendorf, Andrzej ^a   Robinson, Paul A ^b   Clemens, Andreas ^c   Plumb, Jonathan M ^c  

^a Eastgate House   (United Kingdom)

^b BOEHRINGER INGELHEIM LTD   (United Kingdom)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Atrial fibrillation; INR; Stroke; Treatment failure; Warfarin

Indexed keywords

WARFARIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; SEX; STROKE; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; COHORT STUDIES; DRUG MONITORING; FEMALE; HOSPITALIZATION; HUMANS; INTERNATIONAL NORMALIZED RATIO; LENGTH OF STAY; MALE; MEDICAL RECORD LINKAGE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; SURVIVAL ANALYSIS; WALES; WARFARIN; YOUNG ADULT;

EID: 64749108509     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2008.09.016     Document Type: Article

References (21)

1. Rietbrock S., Heeley E., Plumb J., and van Staa T. Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme. American Heart Journal 156 (2008) 57-64
2. Go A.S., Hyled E.M., Phillips K.A., Chang Y.C., Henault L.E., Selby J.V., et al. Prevalence of diagnosed atrial fibrillation in adults. National implications for rhythm management and stroke prevention: the anticoagulation and risk factors study in atrial fibrillation. (ATRIA) Study. Clin Cardiol 285 (2001) 2370-2375
3. Heeringa J., van der Kuip D.A.M., Hofman A., Kors J.A., van Herpen G., Stricker B.H.C.h., et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 27 (2006) 949-953
4. Miyasaka Y., Barnes M.E., Gersh B.J., Cha S.S., Bailey K.R., Abhayaratna W.P., et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 114 (2006) 119-125
5. Wolf P.A., Abbott R.D., and Kannel W. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 22 (1991) 983-988
6. Hart R.G., Pearce L.A., and Aguilar M.I. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 146 (2007) 857-867
7. Menzin J., Boulanger L., Hauch O., Friedman M., Marple C.B., Wygant G., et al. Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial Fibrillation in Clinic Settings: A Multi-Site Managed-Care Study. Ann Pharmacother 39 (2005) 446-451
8. Fuster V., Ryden L.E., Cannom D.S., Crijns H.J., Curtis A.B., Ellenbogen K.A., et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114 7 (2006) 257-354
9. Currie C.J., McEwan P., Emmas C., Morgan C.L., and Peters J.R. Anticoagulation in patients with non-valvular atrial fibrillation: an evaluation of stability and early factors that predict longer-term stability on warfarin in a large UK population. Curr Med Res Opin 21 (2005) 1905-1913
10. Jones M., McEwan P., Morgan C.L., Peters J.R., Goodfellow J., and Currie C.J. Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population. Heart 91 (2005) 472-477
11. Currie C.J., Jones M., Goodfellow J., McEwan P., Morgan C.L., Emmas C., et al. Evaluation of survival and ischaemic and thromboembolic event rates in patients with nonvalvaratrial fibrillation in the general population when treated and untreated with warfarin. Heart 92 (2006) 196-200
12. White H.D., Gruber M., Feyzi J., Kaatz S., Tse H.F., Husted S., et al. Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V. Arch Intern Med 167 (2007) 239-245
13. http://guidance.nice.org.uk/CG36/niceguidance/pdf/English.
14. Gage B.F., Waterman A.D., Shannon W., Boechler M., Rich M.W., and Radford M.J. Validation of clinical classification schemes for predicting stroke. Results from the national registry of atrial fibrillation. JAMA 285 (2001) 2864-2870
15. Gage B.F., van Walraven C., Pearce L Hart R.G., Koudstaal P.J., Boode B.S.P., and Petersen P. Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation 110 (2004) 2287-2292
16. Rosendaal F.R., Cannegieter S.C., van der Meer F.J.M., and Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 69 (1993) 236-239
17. Azar A.J., Deckers J.W., Rosendaal F.R., van Bergen P.F., van der Meer F.J., Jonker J.J., et al. Assessment of therapeutic control in a long-term anticoagulant trial in post-myocardial infarction patients. Thromb Haemost 72 (1993) 347-375
18. Van Walraven C., Gart R.G., Singer D.E., Laupacis A., Connolly S., Petersen P., et al. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation. An individual patient meta-analysis. JAMA 288 (2002) 2441-2448
19. Waldo A.L., Becker R.C., Tapson V.F., and Colgan K.J. Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. J Am Coll Cardiol 46 (2005) 1729-1736
20. Nitsch D., Morton S., DeStavola B.L., Clark H., and Leon D.A. How good is probabilistic record linkage to reconstruct reproductive histories? Results from the Aberdeen children of the 1950s study. BMC Med Res Methodol 22 (2006) 15
21. Atrial Fibrillation Investigators. The efficacy of aspirin in patients with atrial fibrillation: analysis of pooled data from three randomised trials. Arch Intern Med 157 (1997) 1237-1240